Disc Medicine(IRON) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update WATERTOWN, Mass., August 7, 2025 – Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today reported financial results for the second quarter ended June 30, 2025, and provided a recap of recent program and corporate developments. "We are please ...